Company Profile
Friulchem S.p.A. specializes in the research, development, manufacture and marketing of original and generic pharmaceutical products. Net sales by category of products break down as follows:
- veterinary products (59.1%): active pharmaceutical ingredients, antibiotics, antiparasitic and insecticides, anti-inflammatory and cardiotonic ingredients;
- generic products (40.9%): food supplements, cosmetics, etc.
- veterinary products (59.1%): active pharmaceutical ingredients, antibiotics, antiparasitic and insecticides, anti-inflammatory and cardiotonic ingredients;
- generic products (40.9%): food supplements, cosmetics, etc.
Source: Cofisem - Last Update: 2024-04-24
Key Executives
| Chief Executive Officer | |
| Chief Investor Relations Officer |
Source: Cofisem - Last Update: 2024-04-24
Key Figures
| Millenium | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Net sales | 26,657 | 34,261 | 18,494 | 16,667 | 15,642 |
| Consumed purchases | 18,420 | 24,137 | 12,377 | 12,716 | 8,291 |
| Labour costs | 4,508 | 3,967 | 1,822 | 1,914 | 1,696 |
| Operating profit | 593 | 512 | 391 | -308 | 343 |
| Income tax | 95 | -64 | 81 | -167 | 13 |
| Net income | -371 | 7 | 10 | -311 | 63 |
| Net income (Group share) | -227 | 34 | 10 | -311 | 63 |
| Fiscal year end | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | Local GAAP | Local GAAP | Local GAAP | Local GAAP | Local GAAP |
Source: Cofisem - Last Update: 2024-04-24
Shareholder information
| Evultis SA | |
| Fiduciaria Bernasconi SA | |
| Free float | |
| Friulia S.p.A. |
Source: Cofisem - Last Update: 2024-04-24
Address
Please contact MyQuestion.Italy@euronext.com for Company Profile support.